Trial Profile
Lamictal in the Treatment of Post-Herpetic Neuralgia-A Safety, Efficacy,Randomized, Double Blind, Placebo Controlled, Cross-Over Study
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- 06 Apr 2010 Actual initiation date (Feb 2005) added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Oct 2006 New trial record.